Event Date
An inspiring and informative presentation from Dr. Kyle Fink of the UC Davis Gene Therapy Center, a leading researcher advancing breakthrough therapies for rare neurodevelopmental disorders.
Dr. Fink will share how UC Davis is working to accelerate a promising new treatment approach for ADNP syndrome, a rare genetic condition and one of the most common single-gene causes of autism. Affecting brain development and function at the most fundamental level, ADNP syndrome can cause profound developmental, neurological, and physical challenges for children and families.
In this presentation, Dr. Fink will explore why ADNP plays such a critical role in human biology, what researchers are learning about how restoring ADNP activity may improve brain function, and why this moment represents a major turning point in the field. He will also discuss UC Davis’s uniquely powerful translational research model, which combines gene therapy innovation, stem cell science, and human-based testing systems to move potential treatments toward the clinic with unusual speed and precision.
Drawing on years of success developing therapies for disorders such as Rett syndrome, Angelman syndrome, Pitt Hopkins Syndrome, and Juvenile Huntington’s Disease, Dr. Fink brings both scientific expertise and real momentum to this work. Attendees will gain an inside look at how cutting-edge research is opening new possibilities for children with ADNP syndrome and what it takes to move a discovery from the lab toward a future clinical trial.